salubrinal,
salubrinal,
405060-95-9,
eIF-2alpha Inhibitor, Salubrinal,
N-(2,2,2-trichloro-1-(3-(quinolin-8-yl)thioureido)ethyl)cinnamamide,
(E)-3-phenyl-N-[2,2,2-trichloro-1-(quinolin-8-ylcarbamothioylamino)ethyl]prop-2-enamide,
3-Phenyl-N-[2,2,2-trichloro-1-(3-quinolin-8-yl-thioureido)-ethyl]-acrylamide,
BAS 00247559,
AC1NX1CD,
C21H17Cl3N4OS,
CHEMBL180127,
SCHEMBL6477826,
SCHEMBL6477833,
SCHEMBL17360638,
CHEBI:91873,
DTXSID70420852,
CHEBI:131923,
HMS3677G22,
BCP06507,
EX-A2153,
2699AH,
s2923,
STL253110,
AKOS000525027,
AKOS016042385,
CS-1012,
3-Phenyl-N-[2,2,2-trichloro-1-[[(8-quinolinylamino)thioxomethyl]amino]ethyl]-2-propenamide,
NCGC00159554-01,
BC600374,
HY-15486,
NS-05839,
ST078198,
RT-015629,
SW102000-2,
W-5113,
BRD-A77299732-001-01-6,
F0095-1218,
N-(2,2,2-trichloro-1-(3-quinolin-8-ylthioureido)ethyl)cinnamamide,
(2E)-3-phenyl-N-{2,2,2-trichloro-1-[(quinolin-8-ylcarbamothioyl)amino]ethyl}acrylamide,
(E)-3-phenyl-N-[2,2,2-trichloro-1-(8-quinolylcarbamothioylamino)ethyl]prop-2-enamide,
(2E)-3-phenyl-N-(2,2,2-trichloro-1-{[(8-quinolylamino)thioxomethyl]amino}ethyl )prop-2-enamide,
(2E)-3-phenyl-N-(2,2,2-trichloro-1-{[(quinolin-8-yl)carbamothioyl]amino}ethyl)prop-2-enamide,
(2E)-3-phenyl-N-{2,2,2-trichloro-1-[(quinolin-8-ylcarbamothioyl)amino]ethyl}prop-2-enamide,
2-Propenamide,3-phenyl-N-[2,2,2-trichloro-1-[[(8-quinolinylamino)thioxomethyl]amino]ethyl]-,(2E)-,
CID5717801,
C496827,
Sal,
137975-06-5,